Oslo, Norway, December 28, 2021: Harefrøken Invest AS, a legal person closely associated with a person discharging managerial responsibilities in SoftOx Solutions AS, CEO Geir H. Almås, has notified the company of sale of shares in SoftOx Solutions AS, to J G Invest AS, where Kristian Almås is chairman of the board. 

Please refer to the attached for further information.

For further information, please contact:
CEO Geir Almås of SoftOx Solutions AS, or
CFO Kristine Rød of SoftfOx Solutions AS
Mail: ir@soft-ox.com
Mobile: (+47) 948 59 599

The information included in this announcement is defined as inside information
pursuant to MAR article 7, and is publicly disclosed in accordance with MAR
article 17. The announcement is made by the contact person.

About SoftOx Solutions AS
SoftOx Solutions AS (SoftOx, listed on Euronext Growth Oslo) is a Norwegian
BioTech company based in Oslo with the aim of helping to combat major threats to
human health, namely the emergence of antimicrobial resistance (AMR), biofilm
infections in chronic wounds and the spread of viruses. For more information on
SoftOx, visit www.soft-ox.com